ABLI THERAPEUTICS, INC.

Profile

Company Names

ABLI THERAPEUTICS, INC.

Addresses

3350 RIVERWOOD PKWY SE, STE 1900, ATLANTA, GA 30339

Phone Numbers

917-494-0831

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2025

State Incorporated:

DELAWARE

Total Amount Raised:

$1,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2025-09-15 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANASTASIA 
 
DAIFOTIS 
DIRECTOR
ABLI THERAPEUTICS, INC.
GARTH 
 
LEES-ROLFE 
EXECUTIVE OFFICER
INHIBIKASE THERAPEUTICS, INC.   |  ABLI THERAPEUTICS, INC.   |  PANGIA BIOTECH, INC.
MILTON 
H. 
WERNER 
EXECUTIVE OFFICER, DIRECTOR
INHIBIKASE THERAPEUTICS, INC.   |  ABLI THERAPEUTICS, INC.
JEFFREY 
 
YOUNG 
DIRECTOR
ORIGAMI SECONDARY FUND II LP   |  INTEGRATED PLAN DESIGN LLC   |  ORIGAMI OPPORTUNITIES FUND III OFFSHORE MASTER, L.P.   |  ORIGAMI OPPORTUNITIES FUND III, L.P.   |  ORIGAMI OPPORTUNITIES FUND III OFFSHORE, L.P.   |  ORIGAMI DWC, LLC   |  DWC PARENT HOLDINGS LLC   |  AXIAL BIOTHERAPEUTICS, INC.   |  ORIGAMI OPPORTUNITIES FUND IV, L.P.   |  ORIGAMI OPPORTUNITIES FUND IV OFFSHORE, L.P.   |  BIOSTAGE, INC.   |  ABLI THERAPEUTICS, INC.   |  OCP PAYMENTS CV, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-01-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#